Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;18(1 Suppl):S56-61.
doi: 10.1016/j.bbmt.2011.10.001.

The IL-17 differentiation pathway and its role in transplant outcome

Jonathan S Serody  1 , Geoffrey R Hill
Affiliations
Review

The IL-17 differentiation pathway and its role in transplant outcome

Jonathan S Serody et al. Biol Blood Marrow Transplant. 2012 Jan.

Abstract

The limitations of allogeneic transplantation are graft-versus-host disease (both acute and chronic), infection, and relapse. Acute GVHD has traditionally been thought of as a Th1-mediated disease with inflammatory cytokines (eg, interferon [IFN]-γ and tumor necrosis factor [TNF]) and cellular cytolysis mediating apoptotic target tissue damage in skin, gut, and liver. Chronic GVHD has not fit neatly into either Th1 or Th2 (eg, IL-4, IL-13) paradigms. Increasingly, the Th17 pathway of differentiation has been shown to play important roles in acute and chronic GVHD (aGVHD, cGVHD), particularly in relation to skin and lung disease. Here we discuss the IL-17 pathway of T cell differentiation and the accumulating evidence suggesting it represents an important new target for the control of deleterious alloimmune responses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic of the cytokine-dependent control of Th17 differentiation. Adapted from Bettelli et al [53].
See this image and copyright information in PMC

References

    1. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13:139–145. - PubMed
    1. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467–476. - PubMed
    1. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 2008;41:92–104. - PMC - PubMed
    1. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10:225–235. - PMC - PubMed
    1. Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811–821. - PubMed

MeSH terms